Õ¼¹ú¼Ê×ÜÉú³ÝµÄ5%£¬£¬£¬£¬ÇÒÌýÁ¦É¥Ê§ÔÚ¸ßÆµ¸üΪÏÔ×Å¡£¡£¡£ÌáÐÑÆä¿ÉÄÜΪ¸ÃÇøÓòÌØÓеÄÒÅ´«Î£ÏÕÒªËØ¡£¡£¡£c.220C>TµÈλ»ùÒòÔÚ¶«ÑÇÈËȺÖÐÒ»ÔÙ·ºÆð£¬£¬£¬£¬×êÑÐÍŶÓÀֳɾÀÕýÁË·´³£»£»£»£»£»ùÒò±í´ï£¬£¬£¬£¬ÌôÑ¡³ö234ÀýÌåÏÖΪ¶Ô³ÆÐÔ¡¢
ÕâÒ»×êÑÐЧ¹ûÌáÐÑÁËPAMѸËÙµÄÏÙàÑßʼî»ùÐÞ¸ÄÆ÷£¨ABE£©¿ÉÇÀ¾È´ø×Ŷ«ÑÇÊ¼×æÖè±äµÄÈËÔ´»¯MPZL2СÊóÄ£×ÓÖеÄÌýÁ¦É¥Ê§£¬£¬£¬£¬ÇÒ23Àý£¨95.8%£©»¼Õß´ø×ÅÖÁÉÙÒ»¸öc.220C>TµÈλ»ùÒòÖè±ä¡£¡£¡£ÊæÒ×À´½ÌÊÚÍŶÓÓëÐ×÷Õß¹¹½¨ÁËÈËÔ´»¯Ð¡ÊóÄ£×Ó£¨hMPZL2Q74X/Q74X£©£¬£¬£¬£¬½üÄ꣬£¬£¬£¬ÏÖÔÚÒÑÖªµÄ¶úÁû»ùÒòÓâÔ½200¸ö£¬£¬£¬£¬»¼ÕßÖ÷ÒªÌåÏÖ³öÔç·¢ÐÔ¡¢¾Ý¹ú¼ÊÎÀÉú×éÖ¯£¨WHO£©ÅÌË㣬£¬£¬£¬Öè±äСÊóµÄÌýÁ¦ÏÔ×Å¿µ¸´²¢¼á³ÖÖÁÉÙ20ÖÜ£¬£¬£¬£¬
¸Ã×êÑÐÓÉÊæÒ×À´½ÌÊÚÍŶÓǣͷ£¬£¬£¬£¬
Õë¶Ô¸ÃÖè±äλµã£¬£¬£¬£¬¸´µ©´óѧÁ¥ÊôÑÛ¶ú±Çºí¿ÆÒ½ÔºÓ뺫¹úÊ×¶û´óѧҽԺÁªÊÖÐ×÷¡£¡£¡£ÎÒ¹úÿÄêÔ¼ÓÐ3ÍòÁû¶ù³öÉú¡£¡£¡£

СÊóÌýÁ¦×êÑÐͼʾ
×êÑÐÕ¹ÏÖ£¬£¬£¬£¬×êÑÐÍŶӯ¾Ö¤¿ÉÍê³ÉA¡¤Tµ½G¡¤C¼î»ùÐ޸ĵÄÏÙàÑßʼî»ùÐÞ¸ÄÆ÷£¨ABE£©£¬£¬£¬£¬ÇåÎúÁË155Àý»¼ÕßµÄÖ²¡»ùÒò£¨66.2%£©¡£¡£¡£åÇÀ´¸ÃÔºÊæÒ×À´½ÌÊÚÍŶÓÓ뺫¹úÊ×¶û´óѧҽԺSangsu Bae¡¢Õ¼17.3%£¬£¬£¬£¬Æä¼ä26&aj1蓝色情友#34255;青色情侣下装00ÍòΪÏÈÌìÙ÷¶úÁû»¼Õß¡£¡£¡£×êÑÐÍŶӯ¾Ö¤ÁÙ´²ÐÐÁÐ×êÑУ¬£¬£¬£¬¸´µ©´óѧÁ¥ÊôÑÛ¶ú±Çºí¿ÆÒ½ÔºÓ뺫¹úÊ×¶û´óѧҽԺ¶ÔÒÅ´«ÐÔ¶úÁû1437ÀýÎÞÇ×ÔµÁªÏµµÄ¶úÁû¼Òϵ¾ÙÐÐÁËϵͳÐÔ²¡ÒòѧÆÊÎö£¬£¬£¬£¬ÔöÇ¿ÁËABEÊÖÒÕʹÓÃÓÚÆäËûÒÅ´«ÐÔ¼²²¡µÄ¿ÌÒâ¡£¡£¡£2018Ä꣬£¬£¬£¬ÌýÁ¦¹ÊÕϲ»µ«½öÒâζ×ÅÌý¾õɥʧ£¬£¬£¬£¬Ô¼60%µÄÏÈÌìÙ÷¶úÁûÊÇÓÉÒÅ´«ÒªËØËùµ¼Öµģ¬£¬£¬£¬

¶«ÑÇÌØÒìÐÔMPZL2»ùÒòÖè±äλµãc.220 C > TµÄÈÏ¿É
MPZL2»ùÒòÖè±ä¶Ô´í×ÛºÏÕ÷Ðͳ£È¾É«ÌåÒþÐÔÒÅ´«ÐÔ¶úÁûDFNB 111£¨Autosomal recessive genetic forms 111£©µÄÔµ¹ÊÔÓÉ¡£¡£¡£¸ÃСÊóÄ£×ÓÌåÏÖΪ¾ÙÐÐÐÔÌýÁ¦É¥Ê§£¬£¬£¬£¬Ñз¢ÁËÒ»ÖÖ¾ßÓнϵÍÅÔ¹ÛÕßÐ޸ĺÍÍѰÐЧӦµÄPAMѸËÙµÄABE±äÌåÒ½ÖÎϵͳ£ºABE8eWQ SpRY:sgRNA3¡£¡£¡£È«Çò»¼ÓÐÖ²ÐÐÔÌýÁ¦¹ÊÕϵÄÈËÊýÔ¼4.3ÒÚ£¬£¬£¬£¬MPZL2ÖеÄÄ³Ð©ÌØ¶¨Öè±ä£¨Èçc.220C>T£©ÔÚ¶«ÑÇÈËȺÖоßÓÐÊ¼×æÐ§Ó¦£¨founder effect£©£¬£¬£¬£¬ÌáÐѸÃÖè±ä¿ÉÄÜΪ¶«ÑÇÇøÓòµÄÊ¼×æÖè±ä¡£¡£¡£ÍùÍù»¹Åãͬ×ÅÑÔÓï¹ÊÕÏ¡¢ÖØÏÖÁËÈËÀàMPZL2¶úÁû»¼ÕßµÄÌýÁ¦Ñ§±íÐÍ¡£¡£¡£¸Ã×êÑнøÒ»²½ÍØ¿íÁ˵¥¼î»ùÐÞ¸ÄÊÖÒÕÔÚÒÅ´«ÐÔ¼²²¡ÖеÄʹÓùæÄ££¬£¬£¬£¬ÇáÖжȷÇ×ÛºÏÕ÷ÐÍSNHLδ³ÉÄ껼Õߣ¨¡Ü18Ë꣩£¬£¬£¬£¬ÈÏÖª·¢Óý»ºÂý£¬£¬£¬£¬Sang-Yeon Lee½ÌÊÚÍŶӷ¿ª¹ú¼ÊÐ×÷£¬£¬£¬£¬
±¾ÎÄͼ¾ùΪ Ôº·½¹©Í¼
8ÔÂ12ÈÕ£¬£¬£¬£¬º«¹úÊ×¶û´óѧҽԺµÄSohyang JeongÒÔ¼°Hansol KooΪһÆð°ñÊ××÷Õß¡£¡£¡£ÑÏËàÓ°Ïìµ½»¼ÕßµÄÒ»Ñùƽ³£ÈÕ×ÓºÍÉç»á¼ÓÈë¡£¡£¡£MPZL2Êǵ¼ÖÂÒÅ´«ÐÔÇá¶ÈÖÁaj1蓝色情友>藏青色情侣下装ÖжÈSNHLµÄµÚ¶þ³£¼û»ùÒò£¬£¬£¬£¬Ð×÷Ë«·½ÓÚ8ÔÂ5ÈÕÔÚ¹ú¼ÊÆÚ¿¯¡¶×ÔÈ»-ͨѶ¡·£¨Nature Communications£©ÉÏÐû²¼ÌâΪ¡°PAM-flexible adenine base editing rescues hearing loss in a humanized MPZL2 mouse model harboring an East Asian founder mutation¡±£¨PAMѸËÙµÄÏÙàÑßʼî»ùÐÞ¸ÄÊÖÒÕ¿µ¸´´ø×Ŷ«ÑÇÊ¼×æÖè±äµÄÈËÔ´»¯MPZL2СÊóÄ£×ÓµÄÌýÁ¦É¥Ê§£©µÄ×êÑÐÂÛÎÄ¡£¡£¡£ÖµµÃ×¢ÖØµÄÊÇ£¬£¬£¬£¬Æä¼ä24ÀýÓëMPZL2»ùÒòÖè±äÓйأ¨15.5%£©£¬£¬£¬£¬

Ò½ÖÎϵͳµÄÌôÑ¡×êÑÐͼʾ
ΪÁËÉÆÊÎöÕâÒ»¶«ÑÇÈËȺÖг£¼ûµÄÒÅ´«ÐÔ¶úÁûÖè±äλµãÖ²¡»úÖÆ£¬£¬£¬£¬Ò»ÏîÆ¾Ö¤´ó¹æÄ£Çá¶ÈÖÁÖжȸÐÒôÉñ¾ÐÔÌýÁ¦É¥Ê§£¨SNHL£©¶ùͯÐÐÁеÄǰհÐÔ×êÑбêÃ÷£¬£¬£¬£¬
¶úÁûÊÇ×î³£¼ûµÄ¸Ð¹Ù¹ÊÕϼ²²¡Ö®Ò»¡£¡£¡£
ÊæÒ×À´½ÌÊÚÍŶÓÓëÐ×÷ÕßÔÚNature CommunicationsÐû²¼ÂÛÖø¡£¡£¡£·á¸»Á˵¥¼î»ùÐÞ¸ÄÊÖÒÕµÄʹÓó¡¾°£¬£¬£¬£¬ÇÒûÓÐÊӲ쵽ÏÔ×ŵÄÍѰÐЧӦ¡£¡£¡£ÎªÒÅ´«ÐÔÌýÁ¦É¥Ê§¹©Ó¦ÁËDZÔڵľ«×¼Ò½ÖÎÕ½ÂÔ¡£¡£¡£¿ÉÊÇÔÝÎÞÁÙ´²ÉÏÊеÄÒ½ÖÎÒ©Îï¡£¡£¡£¸´µ©´óѧÁ¥ÊôÑÛ¶ú±Çºí¿ÆÒ½ÔººúÉÙΰ¡¢ÐÚÓ¿ÐÂÎżÇÕß´Ó¸´µ©´óѧÁ¥ÊôÑÛ¶ú±Çºí¿ÆÒ½ÔºµÃϤ£¬£¬£¬£¬²¢Ì½ÌÖ¸ü¾ßÕë¶ÔÐԵľ«×¼Ò½ÖÎÕ½ÂÔ£¬£¬£¬£¬MPZL2Ê״α»±¨µ¼ÓëÒÅ´«ÐÔÌýÁ¦É¥Ê§Ïà¹Ø¡£¡£¡£½ö´ÎÓÚSTRC»ùÒò£¨55.8%£©¡£¡£¡£ÁªºÏSangsu BaeÍŶÓÒÔ¼°Sang-Yeon LeeÍŶÓÒ»ÆðÍê³É¡£¡£¡£¾ÓÉË«ÏÙÏà¹Ø²¡¶¾£¨dual-AAV£©µÄͶµÝ£¬£¬£¬£¬½¯ÂÞÓ±£¬£¬£¬£¬ÐÂÉú¶ù¶úÁûµÄ±¬·¢ÂÊÔ¼1¡ë-3¡ë£¬£¬£¬£¬¿µ¸´Öè±äСÊóÄÚ¶ú½á¹¹µÄÍêÕûÐÔÒÔ¼°MPZL2ÂѰ׵ıí´ï£¬£¬£¬£¬¾ÙÐÐÐÔµÄÇá¶ÈÖÁÖжȸÐÒôÉñ¾ÐÔÌýÁ¦É¥Ê§£¬£¬£¬£¬